Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7056)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2020 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Siddiqui MT, Amin H, Garg R, Chadalavada P, Al-Yaman W, Lopez R, Singh A. Medications in type-2 diabetics and their association with liver fibrosis. World J Gastroenterol 2020; 26(23): 3249-3259 [PMID: 32684739 DOI: 10.3748/wjg.v26.i23.3249] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i23/3249.htm |
| Number | Citing Articles |
| 1 |
Tingting Zhou, Ligang Cao, Yimei Du, Lin Qin, Yanliu Lu, Qianru Zhang, Yuqi He, Daopeng Tan. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism. PeerJ 2023; 11: e15225 doi: 10.7717/peerj.15225
|
| 2 |
Timo Itzel, Thomas Falconer, Ana Roig, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias P Ebert, George Hripcsak, Andreas Teufel. Efficacy of Co-Medications in Patients with Alcoholic Liver Disease. Digestive Diseases 2023; 41(5): 780 doi: 10.1159/000529914
|
| 3 |
Carollyne Rodovalho Guerra Carneiro, Arthur Balestra Silveira Ayres, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, Elinton Adami Chaim, Everton Cazzo. Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study. Obesity Surgery 2024; 34(5): 1569 doi: 10.1007/s11695-024-07180-x
|
| 4 |
Clelia Asero, Annalisa Giandalia, Irene Cacciola, Carmela Morace, Giuseppe Lorello, Amalia Rita Caspanello, Angela Alibrandi, Giovanni Squadrito, Giuseppina T. Russo. High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2023; 12(8): 2858 doi: 10.3390/jcm12082858
|
| 5 |
Anqi Zhang, Fangyi Qian, Yangyang Li, Bowen Li, Furong Yang, Chengmu Hu, Wuyi Sun, Yan Huang. Research progress of metformin in the treatment of liver fibrosis. International Immunopharmacology 2023; 116: 109738 doi: 10.1016/j.intimp.2023.109738
|
| 6 |
Chia-Yen Dai, Tzu-Jung Fang, Wei-Wen Hung, Hui-Ju Tsai, Yi-Chun Tsai. The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Biomedicines 2022; 10(7): 1487 doi: 10.3390/biomedicines10071487
|
| 7 |
Jose Arriola-Montenegro, Renato Beas, Renato Cerna-Viacava, Andres Chaponan-Lavalle, Karla Hernandez Randich, Diego Chambergo-Michilot, Herson Flores Sanga, Pornthira Mutirangura. Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease. World Journal of Cardiology 2023; 15(7): 328-341 doi: 10.4330/wjc.v15.i7.328
Abstract(626) |
Core Tip(411) |
Full Article(HTML)(2467)
|
Full Article with Cover (PDF)-1468K(101)
|
Full Article (Word)-335K(88)
|
Audio-441K(1)
|
Peer-Review Report-231K(55)
|
Answering Reviewers-167K(51)
|
Full Article (PDF)-1214K(424)
|
Full Article (XML)-257K(63)
|
Times Cited (2)
|
Total Visits (6232)
|
Open
|
| 8 |
Xiu-Ping Bai, Ting-Ting Li, Lai-Li Guo, Jing Wang, Feng Dong. The Influence of Hyperglycemia on Liver Triglyceride Deposition in
Partially Pancreatectomized Rats. Hormone and Metabolic Research 2024; 56(02): 159 doi: 10.1055/a-2198-1132
|
| 9 |
Federica Perazza, Laura Leoni, Santo Colosimo, Alessandra Musio, Giulia Bocedi, Michela D’Avino, Giulio Agnelli, Alba Nicastri, Chiara Rossetti, Federica Sacilotto, Giulio Marchesini, Maria Letizia Petroni, Federico Ravaioli. Metformin and the Liver: Unlocking the Full Therapeutic Potential. Metabolites 2024; 14(4): 186 doi: 10.3390/metabo14040186
|
| 10 |
Apostolis PAPAEFTHYMIOU, Michael DOULBERIS, Kyriaki KARAFYLLIDOU, Eleftherios CHATZIMICHAEL, Georgia DERETZI, Aristomenis K. EXADAKTYLOS, Fotios SAMPSONAS, Athanasios GELASAKIS, Spyros I. PAPAMICHOS, Georgios KOTRONIS, Dimitra GIALAMPRINOU, Elisabeth VARDAKA, Stergios A. POLYZOS, Jannis KOUNTOURAS. Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. Minerva Endocrinology 2023; 48(3) doi: 10.23736/S2724-6507.21.03564-8
|
| 11 |
Michele Finotti, Maurizio Romano, Pasquale Auricchio, Michele Scopelliti, Marco Brizzolari, Ugo Grossi, Marco Piccino, Stefano Benvenuti, Giovanni Morana, Umberto Cillo, Giacomo Zanus. Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives. Journal of Personalized Medicine 2021; 11(6): 499 doi: 10.3390/jpm11060499
|
| 12 |
Seong-Woo Choi, Sun-Seog Kweon, Young-Hoon Lee, So-Yeon Ryu, Hae-Sung Nam, Min-Ho Shin, Taeyun Kim. Association of liver fibrosis biomarkers with overall and CVD mortality in the Korean population: The Dong-gu study. PLOS ONE 2022; 17(12): e0277729 doi: 10.1371/journal.pone.0277729
|
| 13 |
L. B. Lasebnik, L. N. Chikhireva, O. A. Chikhirev, E. D. Li. Choice of antihyprtensive therapy at varios stages of metabolically associated lever disease. Experimental and Clinical Gastroenterology 2024; (11): 52 doi: 10.31146/1682-8658-ecg-219-11-52-61
|